PULMONX CORP (LUNG) Stock Analyst Ratings
USA - NASDAQ:LUNG - US7458481014 - Common Stock
1.49 USD
-0.1 (-6.29%)
1.51 USD
+0.02 (+1.34%)
ChartMill assigns a Buy % Consensus number of 80% to LUNG. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.89. This target is 362.08% above the current price.
LUNG was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LUNG.
In the previous month the buy percentage consensus was at a similar level.
LUNG was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-28 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-28 | Lake Street | Maintains | Buy -> Buy |
| 2025-09-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-31 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-31 | Lake Street | Maintains | Buy -> Buy |
| 2025-07-31 | Stifel | Maintains | Buy -> Buy |
| 2025-07-31 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-05-22 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-05-01 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-01 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-01 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-03-11 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-10 | D. Boral Capital | Initiate | Buy |
| 2024-12-11 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-12-11 | Citigroup | Downgrade | Buy -> Neutral |
| 2024-10-31 | Stifel | Maintains | Buy -> Buy |
| 2024-08-01 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-01 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-06-04 | Lake Street | Initiate | Buy |
| 2024-05-02 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-04-03 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-02-23 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-02-23 | Citigroup | Maintains | Buy -> Buy |
| 2024-02-22 | Stifel | Maintains | Buy -> Buy |
| 2024-02-22 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-02-22 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-31 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-10-31 | Piper Sandler | Maintains | Overweight -> Overweight |
PULMONX CORP / LUNG FAQ
What is the price target for LUNG stock?
12 analysts have analysed LUNG and the average price target is 6.89 USD. This implies a price increase of 362.08% is expected in the next year compared to the current price of 1.49.
What is the consensus rating for LUNG stock?
The consensus rating for PULMONX CORP (LUNG) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for LUNG stock?
The number of analysts covering PULMONX CORP (LUNG) is 12.